3x5 Partners - Unicorn Nest

3x5 Partners

About

The fund generally invests in less than 2 deals every year. This fund was the most active in 2017. In addition, the fund was active in 2019. Deals in the range of 10 - 50 millions dollars are most common for this fund. We recorded the biggest number of exits for this fund in 2018.

The usual method for the fund is to invest in rounds with 4-5 other investors. Besides 3x5 Partners, start-ups are typically funded by RiverVest, Roche Venture Fund, Novo Ventures and 1 more VC. The fund often co-invests with RiverVest, Roche Venture Fund, Samsara BioCapital.

The average start-up age at the time of investment by this fund is 2-3. Good Therapeutics, Allakos are among the most popular portfolio start-ups of the fund. The fund has a preferred number of founders for start-ups that it invests in. We can highlight the most popular investment areas for this fund, such as Health Care, Food Processing. In addition, there are 3 more industries where it has achieved success.

Fund Activity

Operative

Mail Rule [rules by which you can get an email of an interesting for you fund employee, knowing only the name and surname of this employee]

Domain name: 3x5partners.com; User name format in descending order of probability: first_initial last

Group Appearance [how often fund is operating separately from groups with shared interest]

100.0% of cases

Average Multiplicator [the average ratio of the last valuation of portfolio startups to their total amount of financing raised]

x6

Average Portfolio Company
Exit Age [the average age of portfolio startups at which they go public or become acquired]

5.4 years

Success / Strategy Similarity
Index [the matching between fund's investment strategy and its proved successes in the form of portfolio startups high valuations]

0.6 out of 1

Funds Investing in Previous
Rounds

RiverVest, Roche Venture Fund, Novo Ventures

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: